Hetzer Medical Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 5.4× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 25.57M). Which is the better fit depends on your goals.
| MEDS | RSCH | |
|---|---|---|
Market Cap | 126.56B | 678.4B |
Volume | 319.74M | 25.57M |
Lot | 3.2M | 255.67K |
Turnover | 27.4B | 6.57B |
Average Price | 85.68 | 256.8 |
Value | 27.4B | 6.57B |
Indicative Equilibrium Price | 82 | 258 |
Indicative Equilibrium Volume | 12.79K | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →